ConforMIS, Inc. (NASDAQ:CFMS) Director Philipp Lang sold 137,968 shares of the company’s stock in a transaction on Wednesday, February 15th. The stock was sold at an average price of $8.60, for a total transaction of $1,186,524.80. Following the sale, the director now directly owns 558,759 shares of the company’s stock, valued at $4,805,327.40. The transaction was disclosed in a filing with the SEC, which is available at the SEC website.

Philipp Lang also recently made the following trade(s):

  • On Friday, February 3rd, Philipp Lang sold 108,705 shares of ConforMIS stock. The stock was sold at an average price of $8.60, for a total transaction of $934,863.00.
  • On Wednesday, January 25th, Philipp Lang sold 108,985 shares of ConforMIS stock. The stock was sold at an average price of $8.60, for a total transaction of $937,271.00.
  • On Monday, January 23rd, Philipp Lang sold 9,681 shares of ConforMIS stock. The stock was sold at an average price of $8.60, for a total transaction of $83,256.60.
  • On Friday, January 13th, Philipp Lang sold 37,275 shares of ConforMIS stock. The stock was sold at an average price of $8.60, for a total transaction of $320,565.00.
  • On Wednesday, January 11th, Philipp Lang sold 2,800 shares of ConforMIS stock. The stock was sold at an average price of $8.62, for a total transaction of $24,136.00.
  • On Monday, January 9th, Philipp Lang sold 6,200 shares of ConforMIS stock. The stock was sold at an average price of $8.65, for a total transaction of $53,630.00.
  • On Tuesday, January 10th, Philipp Lang sold 83,909 shares of ConforMIS stock. The stock was sold at an average price of $8.64, for a total transaction of $724,973.76.
  • On Thursday, January 5th, Philipp Lang sold 400 shares of ConforMIS stock. The stock was sold at an average price of $8.60, for a total transaction of $3,440.00.
  • On Tuesday, January 3rd, Philipp Lang sold 74,876 shares of ConforMIS stock. The stock was sold at an average price of $8.00, for a total transaction of $599,008.00.
  • On Friday, December 30th, Philipp Lang sold 168,734 shares of ConforMIS stock. The stock was sold at an average price of $8.25, for a total transaction of $1,392,055.50.

Shares of ConforMIS, Inc. (NASDAQ:CFMS) traded down 30.64% during mid-day trading on Thursday, reaching $5.93. ConforMIS, Inc. has a 12-month low of $4.80 and a 12-month high of $13.83. The stock has a 50 day moving average price of $8.31 and a 200 day moving average price of $8.59. The stock’s market cap is $254.30 million.

ConforMIS (NASDAQ:CFMS) last announced its quarterly earnings results on Wednesday, February 15th. The company reported ($0.37) earnings per share for the quarter, missing the Zacks’ consensus estimate of ($0.30) by $0.07. ConforMIS had a negative net margin of 73.53% and a negative return on equity of 46.41%. The company earned $21.70 million during the quarter, compared to the consensus estimate of $21.37 million. Equities analysts anticipate that ConforMIS, Inc. will post ($1.31) earnings per share for the current year.

Insider Buying and Selling by Quarter for ConforMIS (NASDAQ:CFMS)

“Insider Selling: ConforMIS, Inc. (CFMS) Director Sells 137,968 Shares of Stock” was first reported by Watch List News and is the sole property of of Watch List News. If you are viewing this piece on another domain, it was illegally stolen and republished in violation of U.S. & international trademark and copyright law. The original version of this piece can be viewed at http://www.watchlistnews.com/insider-selling-conformis-inc-cfms-director-sells-137968-shares-of-stock/1121394.html.

Hedge funds and other institutional investors have recently made changes to their positions in the stock. Papp L Roy & Associates bought a new position in shares of ConforMIS during the third quarter worth $106,000. Trent Capital Management Inc. NC bought a new position in shares of ConforMIS during the fourth quarter worth $177,000. A.R.T. Advisors LLC bought a new position in shares of ConforMIS during the fourth quarter worth $178,000. Metropolitan Life Insurance Co. NY bought a new position in shares of ConforMIS during the second quarter worth $204,000. Finally, Russell Investments Group Ltd. bought a new position in shares of ConforMIS during the fourth quarter worth $311,000. 39.63% of the stock is currently owned by hedge funds and other institutional investors.

CFMS has been the subject of several recent analyst reports. Canaccord Genuity set a $12.00 price objective on shares of ConforMIS and gave the stock a “buy” rating in a report on Monday, January 23rd. B. Riley reaffirmed a “buy” rating and set a $13.00 price objective on shares of ConforMIS in a report on Friday, November 4th. Zacks Investment Research downgraded shares of ConforMIS from a “buy” rating to a “hold” rating in a report on Monday, January 9th. Oppenheimer Holdings, Inc. set a $13.00 price objective on shares of ConforMIS and gave the stock a “buy” rating in a report on Monday, October 24th. Finally, J P Morgan Chase & Co reaffirmed a “hold” rating and set a $11.00 price objective on shares of ConforMIS in a report on Friday, November 4th. Three analysts have rated the stock with a hold rating and five have assigned a buy rating to the company. ConforMIS has an average rating of “Buy” and an average price target of $10.61.

About ConforMIS

ConforMIS, Inc is a medical technology company that uses its iFit Image-to-Implant technology platform to develop, manufacture and sell joint replacement implants. The Company’s products include iTotal CR, which is the cruciate-retaining, customized total knee replacement system to restore the natural shape of a patient’s knee; iTotal PS, which is the posterior cruciate ligament substituting, or posterior-stabilized, customized total knee replacement product to restore the natural shape of a patient’s knee; iDuo, which is the customized bicompartmental knee replacement system, and iUni, which is the customized unicompartmental knee replacement product for treatment of the medial or lateral compartment of the knee.

5 Day Chart for NASDAQ:CFMS

Receive News & Ratings for ConforMIS Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ConforMIS Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.